Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1993
10/28/1993WO1993020843A1 Oral treatment of helicobacter infection
10/28/1993WO1993020831A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins
10/28/1993WO1993020826A1 Pharmaceutical composition
10/28/1993WO1993020812A1 Potentiation of antimicrobial effects
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993WO1993013797A3 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
10/28/1993CA2133346A1 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo¬3,2-d|pyrimidine and pharmaceutical uses and compositions containing the same
10/28/1993CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/28/1993CA2118324A1 Substituted indolizino¬1,2-b|quinolinones
10/28/1993CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein
10/28/1993CA2117899A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
10/28/1993CA2111189A1 Oral treatment of helicobacter infection
10/27/1993EP0567216A1 Composition comprising omega-3 fatty acid source and glutathione stimulator for the treatment of immunedisorders and viral infections
10/27/1993EP0567100A1 Mutant respiratory syncytial virus (RSV) vaccines containing same and methods of use
10/27/1993EP0566971A1 Use of L-carnitine for the treatment of shock
10/27/1993EP0566666A1 Novel glucohydrolase inhibitors useful as antidiabetic agents
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993CN1022570C Process for preparing antiviral compounds
10/27/1993CN1022569C Method for mfg. of tylosin and 10,11,12,13-tetrahydro-tylosin derivs.
10/26/1993US5256767 Retroviral antigens
10/26/1993US5256700 Carnosic acid obtention and uses
10/26/1993US5256646 Antiviral antibiotic BU-4224V
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993US5256416 Extracts of the Acanthospermum hispidum plant
10/25/1993CA2094797A1 Method of treating and preventing viral infections using hbnf and mk protein
10/24/1993CA2094311A1 Method of reducing or preventing toxicity associated with antiretroviral therapy
10/21/1993DE4212628A1 Neue Bis-phenyl-hexene New bis-phenyl-hexene
10/20/1993EP0566556A1 2-Substituted tertiary carbinol derivatives of 1,5-iminosugars as antiviral compounds
10/20/1993EP0566446A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy
10/20/1993EP0566445A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy
10/20/1993EP0566237A2 Retroviral protease inhibitors
10/20/1993EP0566199A1 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use a s antiviral agents
10/20/1993EP0565708A1 Vaccine against pathogens of mucosae using liposomes
10/20/1993EP0565650A1 Anti-microbial mafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor
10/20/1993EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
10/20/1993EP0563389A4 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
10/20/1993EP0533795A4 Composition of and treatment with biologically active peptides having d-amino acid residues
10/20/1993EP0413692B1 Use of hexatriene derivatives for the manufacture of preparations for treating acne, psoriasis and light-induced damage to the skin
10/20/1993EP0356484B1 Process for preparation of aloe products
10/20/1993EP0338042B1 Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil
10/20/1993CN1077454A 2-amino-7-((1,3-dihydroxy-2-propoxy) methyl) purine carboxylate, their process of preparation and use
10/19/1993US5254731 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing them, and preparation processes
10/19/1993US5254728 Complexes containing S(+)-phenyl alkanoic acids and α-hydroxyalkanoic
10/19/1993US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
10/19/1993US5254680 Elastase inhibitors
10/19/1993US5254540 Copolymerizing oligosaccharide with nitrogen containing compound; quaternization
10/19/1993US5254535 Composition and treatment with biologically active peptides and antibiotic
10/19/1993US5254340 Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by Haemophilus pleuropneumoniae and a method for obtaining extracellular proteinaceous material of Haemophilus pleuropneumoniae for use in such vaccines
10/19/1993CA1323368C 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines
10/19/1993CA1323306C Pharmacological agent-lipid solution preparation
10/17/1993CA2094082A1 Substituted azetidinyle pyridone derivatives, antimicrobial agents
10/14/1993WO1993020220A1 Non-infectious hiv particles and uses therefor
10/14/1993WO1993020212A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
10/14/1993WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020186A1 In vitro generation of human dendritic cells and uses thereof
10/14/1993WO1993020101A1 Inhibitor of protein kinase c
10/14/1993WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus
10/14/1993WO1993020082A1 Calanolide antiviral compounds, compositions and uses thereof
10/14/1993WO1993020072A1 (furan-2-yl)-2-(1-normon-2-yl) oxazole derivatives with antibacterial activity
10/14/1993WO1993020055A1 Antiproliferative quinazolines
10/14/1993WO1993020046A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for preparation of same and their use as therapeutic agents
10/14/1993WO1993020045A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for the preparation of same and their application as therapeutic agents
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/14/1993WO1993019780A1 Hepatitis vaccines containing 3-o-deacylated monophoshoryl lipid a
10/14/1993WO1993019779A1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
10/14/1993WO1993019767A1 Cd28 pathway immunoregulation
10/14/1993WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/14/1993WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/14/1993WO1993014208A3 Hepatitis e virus vaccine and method
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/14/1993CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993CA2133075A1 CD28 Pathway Immunoregulation
10/14/1993CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993CA2117884A1 Non-infectious hiv particles and uses therefor
10/13/1993EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
10/13/1993EP0565412A1 Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections
10/13/1993EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment
10/13/1993EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1
10/13/1993EP0565132A2 Benzoheterocyclic compounds
10/13/1993EP0564645A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
10/13/1993EP0564620A1 Dermatomycosis vaccine
10/13/1993EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus
10/13/1993EP0564479A1 Thiangazole, its preparation, compositions and use thereof
10/13/1993EP0431076B1 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
10/13/1993CN1077199A Therapeutic nucleosides
10/12/1993US5252728 Process for obtaining polymers with antiviral activity
10/12/1993US5252480 Human monoclonal antibody and hybridoma producing the same
10/12/1993CA1323029C 2-oxo-1-[(substituted sulfonyl)amino]carbonyl]azetidines
10/12/1993CA1323026C Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza- 9a-homoerythromycin a derivatives
10/11/1993CA2093778A1 Heterocyclic compounds
10/09/1993CA2093163A1 Method and composition for treating immune disorders, inflammation and chronic infections
10/07/1993CA2092356A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/06/1993EP0564270A1 An isoxazolidinyl carbapenem derivative
1 ... 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 ... 1798